Navigation Links
AAPM statement on quality radiation therapy
Date:1/29/2010

College Park, MD (January 28, 2010) -- The American Association of Physicists in Medicine (AAPM) has issued a statement today in the wake of several recent articles in the New York Times yesterday and earlier in the week that discuss a number of rare but tragic events in the last decade involving people undergoing radiation therapy.

While it does not specifically comment on the details of these events, the statement acknowledges their gravity. It reads in part: "The AAPM and its members deeply regret that these events have occurred, and we continue to work hard to reduce the likelihood of similar events in the future." The full statement appears at: http://www.aapm.org/publicgeneral/QualityRadiationTherapy.asp

Today's statement also seeks to reassure the public on the safety of radiation therapy, which is safely and effectively used to treat hundreds of thousands of people with cancer and other diseases every year in the United States. Medical physicists in hospitals and clinics across the United States are board-certified professionals who play a key role in assuring quality during these treatments because they are directly responsible for overseeing the complex technical equipment used.

"The primary day-to-day responsibility of our members is to safeguard the welfare of people undergoing radiation therapy," says AAPM President Michael G. Herman, Ph.D. FAAPM, FACMP. "While adverse events during such treatments are very rare, the recent articles serve as a poignant reminder that they still occur, and like all medical professionals, we are deeply saddened by the stories of human tragedy when they do."

As an organization AAPM has always worked hard to reduce the risk of such adverse events through education, quality, and safety initiatives, and today's statement outlines some of these, adds Dr. Herman. For instance, AAPM already has plans in the works for a cross-disciplinary national summit in June that aims to identify ways of enhancing the safety and effectiveness of human radiation therapy.

"As we continue to support high-quality radiation therapy for every patient in the fight against cancer, AAPM remains committed to identifying and implementing opportunities to improve safety," says Dr. Herman, who is a professor and director of the Medical Physics Division in the Department of Radiation Oncology at Mayo Clinic. "We will achieve this through enhancing routine quality performance in a practical manner for the treatment team, helping to facilitate consistent, national radiation therapy event reporting, and continuing to identify and surmount barriers to improved safety.


'/>"/>

Contact: Jason Bardi
jbardi@aip.org
301-209-3091
American Institute of Physics
Source:Eurekalert

Related medicine news :

1. Statement From American Heart Association CEO Nancy Brown on President Obamas State of the Union Address
2. Statement from the Consumer Healthcare Products Association on Mississippi Bill that Seeks to Make Cold, Allergy Medicines Containing Pseudoephedrine Prescription-Only
3. Statement from RC Cancer Centers Regarding News Story on Radiation Oncology
4. Statement From the American Health Care Association and National Center for Assisted Living in Anticipation of President Obamas State of the Union Address
5. SEIU-UHW Statement on Kaiser Union Election in Southern California
6. Operation Rescues Advisory Board Issues Statement on Mr. Terrys Extremism
7. Statement: Helping the UN Help Haiti
8. Pelosi Statement on New Report That Health Reform Will Create 4 Million More Jobs Over the Next Decade
9. Statement by Blue Shield of California CEO Bruce Bodaken Regarding the Groundbreaking for the Family Violence Prevention Funds International Center
10. Statement of US Secretary of Labor Hilda L. Solis on December 2009 employment numbers
11. FRC Statement on the Christmas Eve Passage of the Health Care Reform Bill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... , ... December 04, 2016 , ... ... major cosmetic surgery can now take advantage of a cosmetic procedure known as ... rejuvenation treatment that reduces the appearance of age spots, fine lines, uneven ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges ... brush properly to achieve optimal results. This important necessity inspired an inventor from Las ... a way to ensure that people break or avoid bad techniques of brushing the ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will host ... honoring the 2016 MPN Heroes—eight individuals who have made a difference in the field ... the standard of care, demonstrating leadership within the MPN community and/or a commitment to ...
(Date:12/2/2016)... Dothan, AL (PRWEB) , ... December 02, 2016 ... ... leaders from across the Dothan-Wiregrass Area in Alabama are expected to attend the ... Mike Schmitz, will help provide scholarship funds for area students and operating support ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016 ... hydroxyurea (HU) in Complete Hematologic Response (CHR) ... ropeginterferon alfa-2b versus HU AOP will submit ... CONTINUATION-PV to obtain European marketing authorization in the coming months ... the FDA as it seeks approval for commercialization in the ...
(Date:12/4/2016)... 2016 Sickle cell disease (SCD) is an ... cells that get stuck in veins and block blood ... and complications leading to death. Each year, approximately 300,000 ... most of them lack access to comprehensive care or ... therapy for SCD, a pill called hydroxyurea approved more ...
(Date:12/2/2016)... SILVER SPRING, Md. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... a new indication for Jardiance (empagliflozin) to reduce the ... 2 diabetes mellitus and cardiovascular disease. ... adults with type 2 diabetes mellitus," said Jean-Marc ... Metabolism and Endocrinology Products in FDA,s Center for Drug ...
Breaking Medicine Technology: